Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Clin Immunol. 2020 Jan 8;211:108342. doi: 10.1016/j.clim.2020.108342

Table 6.

Associations Between Methotrexate Use and Cytokine Expression After Activation of PBMCs With Immunostimulants

Association

Time Stimulant Positive Negative

Visit 1 CD3/CD28 Factor 1*, factor 2*, factor 3*, IL-5**, IL-10*, IL-13*, IL-6**, GM-CSF*, MCP-1*a, MIP-1β*
PHA
PMA/Ion Factor 3**, IL-5***, IL-13**
SEA/SEB IL-6**
CpG IL-10*a
Medium IL-6*a
Change between visits CD3/CD28 Factor 1*, factor 2**, Factor 3*, IL-8*a IL-2* IL-8*a
PHA
PMA/Ion Factor 3*
SEA/SEB
CpG Factor 2*, factor 3*, IFN-γ*, IL-5*, MCP-1*a
Medium
Visit 2 CD3/CD28 Factor 1*, factor 2*, factor 3*, IL-1β***, IL-2* IL-5*, IL-8*a
PHA
PMA/Ion
SEA/SEB
CpG Factor 2*, IFN-γ*.
Medium

Abbreviations: CD3/CD28, anti-CD3 and anti-CD28 microbeads; CpG, cytosine-phosphate-guanine oligonucleotide ODN2006; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; MCP, monocyte chemoattractant protein; Medium, RPMI 1640 medium with 10% fetal calf serum; MIP, macrophage inflammatory protein; PBMC, peripheral blood mononuclear cell; PHA, phytohemagglutinin; PMA/Ion, phorbol 12-myristate 13-acetate–ionomycin; SEA/SEB, staphylococcal enterotoxins A and B; TNF, tumor necrosis factor.

a

Cytokine that was not loaded into a factor at 0.5 or more.

*

P<.05.

**

P≤.01.

***

P≤.001.